Program Description

Annual WCIRDC Program Description

The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 14th year, is a unique and exciting multidisciplinary program. The Congress is the premiere global meeting dedicated to diabetes, obesity, metabolism, and energy balance, linking research to clinical practice, and highlighting our theme — Exploring New Frontiers in Metabolism — Tomorrow’s Clinical Science Today.

For more than a decade, the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) has brought researchers, physicians, and other clinicians & healthcare professionals together for a distinctive international program that bridges  bench  to bedside. WCIRDC offers attendees a unique experience,  interacting with the distinguished global faculty  experiencing a program, which promotes a new understanding of metabolic diseases; facilitate the development of future therapeutic modalities; and implement the management of obesity and diabetes focusing on lifestyle and beyond,  evaluating contemporary medications, devices and surgeries to preventing CVD and other complications.

Since Dr. Gerald Reaven’s pioneering work crystallized the relationship between insulin resistance (IR,) diabetes and cardiovascular disease (CVD), the Congress’ focus has expanded to evaluating both clinical and basic science aspects of diabetes, obesity, and CVD, focusing not just on insulin resistance, but also on hyperinsulinemia, fat cell, incretins, the gut, the brain, the kidney and energy metabolism, cardiovascular complications and cancer.  Addressing other components of insulin resistance, endothelial dysfunction, lipid abnormalities, hypertension (HTN), hyperglycemia, and hypercoagulation. The goal is to understand the pathophysiology and the epidemic of obesity, diabetes and to develop appropriate comprehensive clinical management plans.

Some highlight of this year’s program, on top of the general scientific spectrum of the Congress,  include focus on congestive heart failure (CHF), whole body glucose homeostasis, circadian rhythm, IGF1 and metabolism, lipids, statins and complications  Addressing new therapeutic modalities to allow clinical management of these conditions is a key feature of the Congress.

For the specialists and primary care clinician, the Congress will feature a series of workshops and “meet the expert” panels,  addressing the clinical management of Kidney disease, diabetes, obesity, lipids, the high risk CVD patients and more. To make basic and clinical research topics  in metabolism, vascular biology, fat cell, inflammation, immunology, and the endothelium relevant to clinical medicine, there will be a panel discussion and clinical implications commentaries, by recognized clinical experts. The  strength and advantage of the Congress is its intimate setting promoting personal and  direct contact between participants and the distinguished faculty.

The Congress attracts state-of-the-art abstracts from around the globe. These abstracts will be published in Endocrine Practice, the official journal of the American Association of Clinical Endocrinologists (AACE). Typically, articles about the meeting are published in several medical journals, such as Endocrine Practice, Metabolism, The Journal of Diabetes, and Diabetes Care.

 

Exhibit

You are cordially invited to become an exhibitor of the 14th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC).

The 14th WCIRDC will be held on December 1-3, 2016 in California at the Hilton Universal City hotel.

We offer Exhibit space to expand your company’s appreciation, and to expose your products and services to the nearly 500 health care professionals who attend the annual meeting.
WCIRDC is committed to give exhibitors the best value for their participation.

The WCIRDC is an excellent opportunity to meet with globally-recognized medical leaders, clinicians and scientists who present and share their knowledge. The WCIRDC is designed to evaluate both clinical and basic science aspects of insulin resistance, obesity, diabetes, and CVD.

The WCIRDC achieves a great balance between clinical practice and research, by utilizing a state of the art approach: “Exploring New Frontiers in Metabolism – Tomorrow’s Clinical Science Today!”

The WCIRDC will dedicate an area, separate from the educational program, where your company will be able to exhibit products, equipment and services.